Adamis Pharmaceuticals (NASDAQ:ADMP) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Get Rating) in a research report report published on Saturday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Adamis Pharmaceuticals Price Performance Shares of NASDAQ ADMP opened at $0.07 on Friday. The firm has a fifty day moving average price of […]